Internal Reference Number: FOI_7724
Date Request Received: 02/02/2024 00:00:00
Date Request Replied To: 21/02/2024 00:00:00
This response was sent via: By Email
Request Summary: request on biologic medicines in gastroenterology
Request Category: Companies
| Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab | |
| Answer To Question 1: • Adalimumab - Humira - 9 • Adalimumab Biosimilar - 40 • Etrasimod - N/A not used at SFT • Filgotinib - 14 • Golimumab - <5 • Infliximab - Remicade - 19 • Infliximab Biosimilar - 188 • Mirikizumab - N/A not used at SFT • Ozanimod - N/A not used at SFT • Risankizumab - 0 • Tofacitinib - <5 • Upadacitinib - 9 • Ustekinumab - 53 • Vedolizumab - 89 | |
| Question Number 2: If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab | |
| Answer To Question 2: • Adalimumab - Humira - 9 • Adalimumab Biosimilar - 8 • Etrasimod - 0 • Filgotinib - 9 • Golimumab - <5 • Infliximab - Remicade - 6 • Infliximab Biosimilar - 76 • Mirikizumab - 0 • Ozanimod - 0 • Risankizumab - 0 • Tofacitinib - <5 • Upadacitinib - <5 • Ustekinumab - 10 • Vedolizumab - 45 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
